The United States Attorney’s Office for the Southern District of New York is pursuing criminal charges against the executive of a drug-compounding company over what it alleges to be an unlawful conspiracy between them and a number of equine veterinarians.
Specifically, the indictment accuses the executive “with participating in a conspiracy to distribute an adulterated or misbranded equine drug with intent to defraud and mislead in violation of [federal law]”
This content is for subscribers to Equine Law & Business Letter. Please log in, or subscribe here.